Medical Institute Ministry Of Interior
- Address
- lock Available on a paid plan
Cardiovascular Disease Research
The Neurology Clinic at Medical Institute Ministry Of Interior is conducting studies focused on cardiovascular disease, evaluating new treatments aimed at reducing clot formation and preventing major adverse cardiac events.
- Evaluation of novel anticoagulant therapy
- Safety assessment of cardiovascular agents
- Impact on major adverse cardiovascular events
These trials support the institute’s commitment to advancing heart health in the Sofia region.
Multiple Sclerosis Investigations
Researchers are exploring innovative oral therapies for relapsing multiple sclerosis and progressive multiple sclerosis, with goals to lower relapse rates and slow brain atrophy.
- Efficacy measured by MRI lesion count
- Relapse prevention strategies
- Neuroprotective outcomes in progressive disease
The site’s neurologists aim to improve quality of life for patients living with MS.
Diabetes Management Studies
The clinic is testing a once‑weekly insulin analogue for adults with type 2 diabetes, seeking comparable blood‑sugar control to daily basal insulin while simplifying treatment.
- Glycaemic control comparison
- Patient‑reported outcomes
- Long‑term safety monitoring
Findings may help reduce daily injection burden for diabetic patients across Bulgaria.
Chronic Rhinosinusitis Research
A trial evaluates the biologic agent tezepelumab in individuals with chronic rhinosinusitis with nasal polyposis, aiming to lessen nasal congestion and improve sinus symptoms.
- Symptom score reduction
- Quality‑of‑life improvements
- Safety profile of biologic therapy
This work expands the institute’s expertise beyond neurology into ENT conditions.
Respiratory Health Initiatives
While primarily a neurology center, the institute also supports studies addressing respiratory tract diseases, focusing on innovative approaches to manage airway inflammation.
- Evaluation of anti‑inflammatory agents
- Pulmonary function outcomes
- Integration with systemic disease management
Collaborative efforts with pulmonology specialists enhance comprehensive patient care.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 6 therapeutic areas and 14 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Immunic AG2active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Immunic AG3trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medical Institute Ministry Of Interior
lock Showing 1 of 10 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults with Moderate or Severe Diabetic Foot Infections | Micurx Pharmaceuticals Inc. | Phase III | Recruiting | Mar 2023 | — |
IMP list
lock Showing 1 of 14 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Vidofludimus Calcium | 3 | Unknown | 2019-01-23 | 2022-03-01 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.